Feedback / Questions
ADS051 - Adiso Therap
https://www.prnewswire.com/news-releases/adiso-therapeutics-announces-the-completion-of-a-phase-1b-multiple-ascending-dose-study-of-ads051-for-the-treatment-of-moderately-to-severely-active-ulcerative-colitis-301838633.html
May 31, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next